Isis Pharmaceuticals (ISIS)
Create an Alert
22.58
-0.50 -2.17%
NASDAQ
Jun 19, 4:49PM
BATS Real time
Currency in USD
Isis Pharmaceuticals Cash from Investing Quarterly:
-15.31M for March 31, 2013Isis Pharmaceuticals Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -15.31M |
| Dec. 31, 2012 | 5.035M |
| Sept. 30, 2012 | -10.61M |
| June 30, 2012 | 24.09M |
| March 31, 2012 | -0.522M |
| Dec. 31, 2011 | 32.37M |
| Sept. 30, 2011 | -5.702M |
| June 30, 2011 | 24.64M |
| March 31, 2011 | 56.72M |
| Dec. 31, 2010 | -7.242M |
| Sept. 30, 2010 | 75.91M |
| June 30, 2010 | -59.94M |
| March 31, 2010 | 14.96M |
| Dec. 31, 2009 | -15.21M |
| Sept. 30, 2009 | -39.43M |
| June 30, 2009 | -28.73M |
| March 31, 2009 | -128.91M |
| Dec. 31, 2008 | -30.84M |
| Sept. 30, 2008 | -161.64M |
| June 30, 2008 | -29.02M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
ISIS Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Aegerion Pharmaceuticals | -29.50M |
| Sanofi | |
| Biogen Idec | 155.94M |
ISIS Cash from Investing Quarterly Rankings
| Overall |
65th percentile 5757 of 16782 |
| Sector |
49th percentile 710 of 1410 in Healthcare |
| Industry |
39th percentile 275 of 454 in Biotechnology |
ISIS Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -161.64M | Sep 2008 |
| Maximum | 75.91M | Sep 2010 |
| Average | -14.97M |
